News & Events

PALO ALTO, CA, United States - AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today released a copy of its investor presentation, following receipt of its de novo clearance from the United States Food and Drug Administration for AeroForm in late December 2016.
Please view a copy of the investor presentation  here.